Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
19.08
+0.32 (1.71%)
Oct 29, 2026, 9:35 AM EDT - Market open
Immunome Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, Immunome stock has a consensus rating of "Strong Buy" and an average price target of $35.33. The average 1-year stock price forecast is 85.17% higher than the current stock price, while the lowest is $24 (+25.79%) and the highest is $40 (+109.64%).
Price Target: $35.33 (+85.17%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Immunome stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 11 | 11 | 11 | 12 | 13 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 14 | 14 | 14 | 16 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $40 | Buy | Maintains | $40 | +109.64% | Oct 27, 2026 |
| Barclays | Barclays | Buy Maintains $36 | Buy | Maintains | $36 | +88.68% | Oct 27, 2026 |
Unknown Analyst Wedbush No rating | Wedbush | Buy Maintains $35 | Buy | Maintains | $35 | +83.44% | Oct 27, 2026 |
| William Blair | William Blair | Buy Initiates $35 | Buy | Initiates | $35 | +83.44% | Oct 16, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Hold Maintains $24 | Hold | Maintains | $24 | +25.79% | Oct 6, 2026 |
Financial Forecast
Revenue This Year
266.67K
from 6.94M
Decreased by -96.16%
Revenue Next Year
50.41M
from 266.67K
Increased by 18,803.97%
EPS This Year
-2.33
from -2.43
EPS Next Year
-2.46
from -2.33
EPS and Forward PE are based on non-GAAP adjusted numbers.